Hantavirus infections for the clinician: From case presentation to diagnosis and treatment

Critical Reviews in Microbiology

Volumn 38, Issue 4, 2012, Pages 317-329

  Sargianou, Maria ^a   Watson, Dionysios Christos ^a   Chra, Paraskevi ^b   Papa, Anna ^c   Starakis, Ioannis ^a   Gogos, Charalambos ^a   Panos, George ^a  

^a UNIVERSITY GENERAL HOSPITAL OF PATRAS   (Greece)

^b Korgialenio Benakio Hospital   (Greece)

^c ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Clinical; Hantavirus pulmonary syndrome; Hemorrhagic fever with renal syndrome; Pathophysiology; Viral hemorrhagic fever

Indexed keywords

ADRENALIN; ANTIBIOTIC AGENT; DOPAMINE; EPHEDRINE; FUROSEMIDE; HUMAN ALBUMIN; HYPERTENSIVE FACTOR; INOTROPIC AGENT; RIBAVIRIN;

ASIA; BLOOD VESSEL PERMEABILITY; BUNYAVIRUS INFECTION; CARDIOVASCULAR FUNCTION; CRYSTALLOID; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE SEVERITY; EUROPE; EXTRACORPOREAL OXYGENATION; HANTAVIRUS INFECTION; HANTAVIRUS PULMONARY SYNDROME; HEMORRHAGIC FEVER WITH RENAL SYNDROME; HOMEOSTASIS; HUMAN; HYPOTENSION; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY FUNCTION; LYMPHOCYTOSIS; MEDICAL RESEARCH; NEPHROPATHICA EPIDEMICA; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RESPIRATORY FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SCANDINAVIA; SEROLOGY; THROMBOCYTOPENIA; TREATMENT OUTCOME;

ASIA; EUROPE; HANTAVIRUS; HANTAVIRUS INFECTIONS; HUMANS;

HANTAVIRUS; RODENTIA;

EID: 84866978614     PISSN: 1040841X     EISSN: 15497828     Source Type: Journal    
DOI: 10.3109/1040841X.2012.673553     Document Type: Review

References (146)

1. Abel Borges A, Figueiredo LT. (2008). Mechanisms of shock in Hantavirus pulmonary syndrome. Curr Opin Infect Dis, 21, 293-297.
2. Ahlm C, Lindén C, Linderholm M, Alexeyev OA, Billheden J, Elgh F, Fagerlund M, Zetterlund B, Settergren B. (1998). Central nervous system and ophthalmic involvement in nephropathia epidemica (European type of haemorrhagic fever with renal syndrome). J Infect, 36, 149-155.
3. Alexeyev OA, Morozov VG. (1995). Neurological manifestations of hemorrhagic fever with renal syndrome caused by Puumala virus: review of 811 cases. Clin Infect Dis, 20, 255-258.
4. Baek SH, Shin DI, Lee HS, Lee SH, Kim HY, Shin KS, Lee SY, Han HS, Han HJ, Lee SS. (2010). Reversible splenium lesion of the corpus callosum in hemorrhagic fever with renal failure syndrome. J Korean Med Sci, 25, 1244-1246.
5. Battisti AJ, Chu YK, Chipman PR, Kaufmann B, Jonsson CB, Rossmann MG. (2011). Structural studies of Hantaan virus. J Virol, 85, 835-841.
6. Bharadwaj M, Nofchissey R, Goade D, Koster F, Hjelle B. (2000). Humoral immune responses in the Hantavirus cardiopulmonary syndrome. J Infect Dis, 182, 43-48.
7. Bhimma R, Sairam VK, Travis L. (2010). Hemorrhagic Fever With Renal Failure Syndrome. Treatment and Management. Medscape Reference [Online] Available at: http://emedicine.medscape.com/article/982142-treatment. Accessed on 25 February 2012.
8. Bi Z, Formenty PB, Roth CE. (2008). Hantavirus infection: a review and global update. J Infect Dev Ctries, 2, 3-23.
9. Borio L, Inglesby T, Peters CJ, Schmaljohn AL, Hughes JM, Jahrling PB, Ksiazek T, Johnson KM, Meyerhoff A, O'Toole T, Ascher MS, Bartlett J, Breman JG, Eitzen EM Jr, Hamburg M, Hauer J, Henderson DA, Johnson RT, Kwik G, Layton M, Lillibridge S, Nabel GJ, Osterholm MT, Perl TM, Russell P, Tonat K; Working Group on Civilian Biodefense. (2002). Hemorrhagic fever viruses as biological weapons: medical and public health management. JAMA, 287, 2391-2405.
10. Brorstad A, Oscarsson KB, Ahlm C. (2010). Early diagnosis of Hantavirus infection by family doctors can reduce inappropriate antibiotic use and hospitalization. Scand J Prim Health Care, 28, 179-184.
11. Bui-Mansfield LT, Torrington KG, Kim T. (2001). Acute pancreatitis in patients with hemorrhagic fever with renal syndrome. Mil Med, 166, 167-170.
12. Campos GM, Borges AA, Badra SJ, Figueiredo GG, Souza RL, Moreli ML, Figueiredo LT. (2009). Pulmonary and cardiovascular syndrome due to Hantavirus: clinical aspects of an emerging disease in southeastern Brazil. Rev Soc Bras Med Trop, 42, 282-289.
13. Caramello P, Canta F, Bonino L, Moiraghi C, Navone F, Lipani F, Balbiano R, Caputo AM, Gai V. (2002). Puumala virus pulmonary syndrome in a Romanian immigrant. J Travel Med, 9, 326-329.
14. Cebalo L, Dusek T, Kuzman I, Markotic A. (2003). Grading the severity of disease in patients with Puumala or Dobrava virus infections from 1995 to 2000 in Croatia. Acta Med Croatica, 57, 355-359.
15. Cerar D, Avsic-Zupanc T, Jereb M, Strle F. (2007). Case report: severe neurological manifestation of Dobrava Hantavirus infection. J Med Virol, 79, 1841-1843.
16. Chang B, Crowley M, Campen M, Koster F. (2007). Hantavirus cardiopulmonary syndrome. Semin Respir Crit Care Med, 28, 193-200.
17. Chapman LE, Ellis BA, Koster FT, Sotir M, Ksiazek TG, Mertz GJ, Rollin PE, Baum KF, Pavia AT, Christenson JC, Rubin PJ, Jolson HM, Behrman RE, Khan AS, Bell LJ, Simpson GL, Hawk J, Holman RC, Peters CJ; Ribavirin Study Group. (2002). Discriminators between Hantavirus-infected and-uninfected persons enrolled in a trial of intravenous ribavirin for presumptive Hantavirus pulmonary syndrome. Clin Infect Dis, 34, 293-304.
18. Chapman LE, Mertz GJ, Peters CJ, Jolson HM, Khan AS, Ksiazek TG, Koster FT, Baum KF, Rollin PE, Pavia AT, Holman RC, Christenson JC, Rubin PJ, Behrman RE, Bell LJ, Simpson GL, Sadek RF. (1999). Intravenous ribavirin for Hantavirus pulmonary syndrome: safety and tolerance during 1 year of open-label experience. Ribavirin Study Group. Antivir Ther (Lond), 4, 211-219.
19. Chung DH, Kumarapperuma SC, Sun Y, Li Q, Chu YK, Arterburn JB, Parker WB, Smith J, Spik K, Ramanathan HN, Schmaljohn CS, Jonsson CB. (2008). Synthesis of 1-β-D-ribofuranosyl-3-ethynyl-[1,2,4]triazole and its in vitro and in vivo efficacy against Hantavirus. Antiviral Res, 79, 19-27.
20. Chung DH, Strouse JJ, Sun Y, Arterburn JB, Parker WB, Jonsson CB. (2009). Synthesis and anti-Hantaan virus activity of N(1)-3-fluorophenyl-inosine. Antiviral Res, 83, 80-85.
21. Cosgriff TM. (1989). Hemorrhagic fever with renal syndrome: four decades of research. Ann Intern Med, 110, 313-316.
22. Crowcroft NS, Infuso A, Ilef D, Le Guenno B, Desenclos JC, Van Loock F, Clement J. (1999). Risk factors for human Hantavirus infection: Franco-Belgian collaborative case-control study during 1995-6 epidemic. BMJ, 318, 1737-1738.
23. Custer DM, Thompson E, Schmaljohn CS, Ksiazek TG, Hooper JW. (2003). Active and passive vaccination against Hantavirus pulmonary syndrome with Andes virus M genome segment-based DNA vaccine. J Virol, 77, 9894-9905.
24. Deng HY, Luo F, Shi LQ, Zhong Q, Liu YJ, Yang ZQ. (2009). Efficacy of arbidol on lethal Hantaan virus infections in suckling mice and in vitro. Acta Pharmacol Sin, 30, 1015-1024.
25. Dietl CA, Wernly JA, Pett SB, Yassin SF, Sterling JP, Dragan R, Milligan K, Crowley MR. (2008). Extracorporeal membrane oxygenation support improves survival of patients with severe Hantavirus cardiopulmonary syndrome. J Thorac Cardiovasc Surg, 135, 579-584.
26. Duchin JS, Koster FT, Peters CJ, Simpson GL, Tempest B, Zaki SR, Ksiazek TG, Rollin PE, Nichol S, Umland ET. (1994). Hantavirus pulmonary syndrome: a clinical description of 17 patients with a newly recognized disease. The Hantavirus Study Group. N Engl J Med, 330, 949-955.
27. Evander M, Eriksson I, Pettersson L, Juto P, Ahlm C, Olsson GE, Bucht G, Allard A. (2007). Puumala Hantavirus viremia diagnosed by real-time reverse transcriptase PCR using samples from patients with hemorrhagic fever and renal syndrome. J Clin Microbiol, 45, 2491-2497.
28. Ferluga D, Vizjak A. (2008). Hantavirus nephropathy. J Am Soc Nephrol, 19, 1653-1658.
29. Ferres M, Vial P, Marco C, Yanez L, Godoy P, Castillo C, Hjelle B, Delgado I, Lee SJ, Mertz GJ; Andes Virus Household Contacts Study Group. (2007). Prospective evaluation of household contacts of persons with Hantavirus cardiopulmonary syndrome in child. J Infect Dis, 195, 1563-1571.
30. Fu C, Jia H, Gong M. (1998). Therapeutic effect of recombinant interferon α-2b on hemorrhagic fever with renal syndrome. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, 12, 370-372.
31. Fu C, Song S, Shi Y. (1999). Observation on effect of chongcao shenkang capsules in preventing and treating acute renal failure in cases of hemorrhagic fever with renal syndrome. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, 13, 188-190.
32. Gavrilovskaya IN, Gorbunova EE, Mackow ER. (2010). Pathogenic Hantaviruses direct the adherence of quiescent platelets to infected endothelial cells. J Virol, 84, 4832-4839.
33. Gavrilovskaya IN, Gorbunova EE, Mackow NA, Mackow ER. (2008). Hantaviruses direct endothelial cell permeability by sensitizing cells to the vascular permeability factor VEGF, while angiopoietin 1 and sphingosine 1-phosphate inhibit Hantavirus-directed permeability. J Virol, 82, 5797-5806.
34. Gerding MN, Groen J, Jordans JG, Osterhaus AD. (1995). Hantavirus nephropathy in The Netherlands: clinical, histopathological and epidemiological findings. Neth J Med, 47, 106-112.
35. Glass GE, Watson AJ, LeDuc JW, Childs JE. (1994). Domestic cases of hemorrhagic fever with renal syndrome in the United States. Nephron, 68, 48-51.
36. Glass GE, Watson AJ, LeDuc JW, Kelen GD, Quinn TC, Childs JE. (1993). Infection with a ratborne Hantavirus in US residents is consistently associated with hypertensive renal disease. J Infect Dis, 167, 614-620.
37. Gorbunova E, Gavrilovskaya IN, Mackow ER. (2010). Pathogenic Hantaviruses Andes virus and Hantaan virus induce adherens junction disassembly by directing vascular endothelial cadherin internalization in human endothelial cells. J Virol, 84, 7405-7411.
38. Gorbunova EE, Gavrilovskaya IN, Pepini T, Mackow ER. (2011). VEGFR2 and Src kinase inhibitors suppress Andes virus-induced endothelial cell permeability. J Virol, 85, 2296-2303.
39. Gracia F, Armien B, Simpson SQ, Munoz C, Broce C, Pascale JM, Koster F. (2010). Convalescent pulmonary dysfunction following Hantavirus pulmonary syndrome in Panama and the United States. Lung, 188, 387-391.
40. Guilfoyle JF, Macnab AJ. (2008). Hantavirus cardiopulmonary syndrome: implications for transport management and care. Air Med J, 27, 299-302.
41. Han Q, Kang W, Zhang L, Lou S, Zhao Q, Liu Z. (2010). Increased serum fibronectin levels in patients with hemorrhagic fever with renal syndrome. Inflamm Res, 59, 135-139.
42. Hautala T, Mähönen SM, Sironen T, Hautala N, Pääkkö E, Karttunen A, Salmela PI, Ilonen J, Vainio O, Glumoff V, Rytky S, Plyusnin A, Vaheri A, Vapalahti O, Kauma H. (2010). Central nervous systemrelated symptoms and findings are common in acute Puumala Hantavirus infection. Ann Med, 42, 344-351.
43. Heyman P, Vaheri A; ENIVD Members. (2008). Situation of Hantavirus infections and haemorrhagic fever with renal syndrome in European countries as of December 2006. Euro Surveill, 13, 18925.
44. Heyman P, Vaheri A, Lundkvist A, Avsic-Zupanc T. (2009). Hantavirus infections in Europe: from virus carriers to a major public-health problem. Expert Rev Anti Infect Ther, 7, 205-217.
45. Hjelle B, Goade D, Torrez-Martinez N, Lang-Williams M, Kim J, Harris RL, Rawlings JA. (1996). Hantavirus pulmonary syndrome, renal insufficiency, and myositis associated with infection by Bayou Hantavirus. Clin Infect Dis, 23, 495-500.
46. Hjertqvist M, Klein SL, Ahlm C, Klingstrom J. (2010). Mortality rate patterns for hemorrhagic fever with renal syndrome caused by Puumala virus. Emerging Infect Dis, 16, 1584-1586.
47. Hooper JW, Ferro AM, Wahl-Jensen V. (2008). Immune serum produced by DNA vaccination protects hamsters against lethal respiratory challenge with Andes virus. J Virol, 82, 1332-1338.
48. Hopkins RO, Larson-Lohr V, Weaver LK, Bigler ED. (1998). Neuropsychological impairments following Hantavirus pulmonary syndrome. J Int Neuropsychol Soc, 4, 190-196.
49. Huggins JW, Hsiang CM, Cosgriff TM, Guang MY, Smith JI, Wu ZO, LeDuc JW, Zheng ZM, Meegan JM, Wang QN. (1991). Prospective, double-blind, concurrent, placebo-controlled clinical trial of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome. J Infect Dis, 164, 1119-1127.
50. Hujakka H, Koistinen V, Eerikäinen P, Kuronen I, Mononen I, Parviainen M, Lundkvist A, Vaheri A, Närvänen A, Vapalahti O. (2001). New immunochromatographic rapid test for diagnosis of acute Puumala virus infection. J Clin Microbiol, 39, 2146-2150.
51. Hujakka H, Koistinen V, Kuronen I, Eerikäinen P, Parviainen M, Lundkvist A, Vaheri A, Vapalahti O, Närvänen A. (2003). Diagnostic rapid tests for acute Hantavirus infections: specific tests for Hantaan, Dobrava and Puumala viruses versus a Hantavirus combination test. J Virol Methods, 108, 117-122.
52. Hussein IT, Haseeb A, Haque A, Mir MA. (2011). Recent advances in Hantavirus molecular biology and disease. Adv Appl Microbiol, 74, 35-75.
53. Jakab F, Sebok J, Szántó Z, Hang D, Imre M, Németh V, Madai M, Oldal M, Kovács T, Wittmann I. (2011). Dobrava-Belgrade Hantavirus infection mimics acute appendicitis. J Clin Virol, 50, 164-166.
54. Jonsson CB, Figueiredo LT, Vapalahti O. (2010). A global perspective on Hantavirus ecology, epidemiology, and disease. Clin Microbiol Rev, 23, 412-441.
55. Jonsson CB, Hooper J, Mertz G. (2008). Treatment of Hantavirus pulmonary syndrome. Antiviral Res, 78, 162-169.
56. Jonsson CB, Milligan BG, Arterburn JB. (2005). Potential importance of error catastrophe to the development of antiviral strategies for Hantaviruses. Virus Res, 107, 195-205.
57. Kallio-Kokko H, Leveelahti R, Brummer-Korvenkontio M, Lundkvist A, Vaheri A, Vapalahti O. (2001). Human immune response to Puumala virus glycoproteins and nucleocapsid protein expressed in mammalian cells. J Med Virol, 65, 605-613.
58. Kanerva M, Paakkala A, Mustonen J, Paakkala T, Lahtela J, Pasternack A. (1996). Pulmonary involvement in nephropathia epidemica: radiological findings and their clinical correlations. Clin Nephrol, 46, 369-378.
59. Katz S, Leedham CL, Kessler WH. (1952). Medical management of hemorrhagic fever. J Am Med Assoc, 150, 1363-1366.
60. Khaiboullina SF, Morzunov SP, St Jeor SC. (2005). Hantaviruses: molecular biology, evolution and pathogenesis. Curr Mol Med, 5, 773-790.
61. Khan AS, Khabbaz RF, Armstrong LR, Holman RC, Bauer SP, Graber J, Strine T, Miller G, Reef S, Tappero J, Rollin PE, Nichol ST, Zaki SR, Bryan RT, Chapman LE, Peters CJ, Ksiazek TG. (1996). Hantavirus pulmonary syndrome: the first 100 US cases. J Infect Dis, 173, 1297-1303.
62. Kilpatrick ED, Terajima M, Koster FT, Catalina MD, Cruz J, Ennis FA. (2004). Role of specific CD8+ T cells in the severity of a fulminant zoonotic viral hemorrhagic fever, Hantavirus pulmonary syndrome. J Immunol, 172, 3297-3304.
63. Kim BN, Choi BD. (2006). Hemorrhagic fever with renal syndrome complicated with pregnancy: a case report. Korean J Intern Med, 21, 150-153.
64. Kim YO, Chun KA, Choi JY, Yoon SA, Yang CW, Kim KT, Bang BK. (2001). Sonographic evaluation of gallbladder-wall thickening in hemorrhagic fever with renal syndrome: prediction of disease severity. J Clin Ultrasound, 29, 286-289.
65. Kim YK, Lee SC, Kim C, Heo ST, Choi C, Kim JM. (2007). Clinical and laboratory predictors of oliguric renal failure in haemorrhagic fever with renal syndrome caused by Hantaan virus. J Infect, 54, 381-386.
66. Klingström J, Stoltz M, Hardestam J, Ahlm C, Lundkvist A. (2008). Passive immunization protects cynomolgus macaques against Puumala Hantavirus challenge. Antivir Ther (Lond), 13, 125-133.
67. Kontkanen M, Puustjärvi T, Lähdevirta J. (1994). Myopic shift and its mechanism in nephropathia epidemica or Puumala virus infection. Br J Ophthalmol, 78, 903-906.
68. Krautkrämer E, Zeier M. (2008). Hantavirus causing hemorrhagic fever with renal syndrome enters from the apical surface and requires decay-accelerating factor (DAF/CD55). J Virol, 82, 4257-4264.
69. Launay D, Thomas Ch, Fleury D, Roueff S, Line ML, Droz D, Vanhille P. (2003). Pulmonary-renal syndrome due to hemorrhagic fever with renal syndrome: an unusual manifestation of puumala virus infection in France. Clin Nephrol, 59, 297-300.
70. Lednicky JA. (2003). Hantaviruses. a short review. Arch Pathol Lab Med, 127, 30-35.
71. Lee EY, Choi SO, Choi GB, Kang DH, Yoon KI. (1998). Isolated abducens nerve palsy as a complication of haemorrhagic fever with renal syndrome. Nephrol Dial Transplant, 13, 2113-2114.
72. Lindkvist M, Näslund J, Ahlm C, Bucht G. (2008). Cross-reactive and serospecific epitopes of nucleocapsid proteins of three Hantaviruses: prospects for new diagnostic tools. Virus Res, 137, 97-105.
73. Liu YF, Yang SJ, Yan PS, Liu YY. (1994). Characteristics of immunocomplex in autopsy tissues of hemorrhagic fever with renal syndrome. Chin Med J, 107, 444-449.
74. Ma Y, Li Q, Wang J, Xu Z, Song C, Zhuang R, Yang K, Yang A, Jin B. (2010). Cystatin C, a novel urinary biomarker for sensitive detection of acute kidney injury during haemorrhagic fever with renal syndrome. Biomarkers, 15, 410-417.
75. Machado A, de Figueiredo G, dos Santos Jr G, Figueiredo L. (2009). Laboratory diagnosis of human Hantavirus infection: novel insights and future potential. Future Virol, 4, 383-389.
76. Mackow ER, Gavrilovskaya IN. (2009). Hantavirus regulation of endothelial cell functions. Thromb Haemost, 102, 1030-1041.
77. Mäkelä S, Jaatinen P, Miettinen M, Salmi J, Ala-Houhala I, Huhtala H, Hurme M, Pörsti I, Vaheri A, Mustonen J. (2010). Hormonal deficiencies during and after Puumala Hantavirus infection. Eur J Clin Microbiol Infect Dis, 29, 705-713.
78. Martinez VP, Bellomo C, San Juan J, Pinna D, Forlenza R, Elder M, Padula PJ. (2005). Person-to-person transmission of Andes virus. Emerging Infect Dis, 11, 1848-1853.
79. McDermid R, Gibney R, Brisebois R, Skjodt N. (2006). Drotrecogin α (activated) in two patients with the Hantavius cardiopulmonary syndrome. Can Respir J, 13, 272-274.
80. Mentel R, Bordihn N, Wegner U, Wendel H, Niklasson B. (1999). Hantavirus Dobrava infection with pulmonary manifestation. Med Microbiol Immunol, 188, 51-53.
81. Mertz GJ, Hjelle B, Crowley M, Iwamoto G, Tomicic V, Vial PA. (2006). Diagnosis and treatment of new world Hantavirus infections. Curr Opin Infect Dis, 19, 437-442.
82. Mertz GJ, Miedzinski L, Goade D, Pavia AT, Hjelle B, Hansbarger CO, Levy H, Koster FT, Baum K, Lindemulder A, Wang W, Riser L, Fernandez H, Whitley RJ; Collaborative Antiviral Study Group. (2004). Placebo-controlled, double-blind trial of intravenous ribavirin for the treatment of Hantavirus cardiopulmonary syndrome in North America. Clin Infect Dis, 39, 1307-1313.
83. Miettinen MH, Mäkelä SM, Ala-Houhala IO, Huhtala HS, Hurme MA, Kööbi T, Partanen JA, Pasternack AI, Vaheri A, Pörsti IH, Mustonen JT. (2010). The severity of acute Puumala Hantavirus infection does not predict the long-term outcome of patients. Nephron Clin Pract, 116, c89-c94.
84. Miettinen MH, Mäkelä SM, Ala-Houhala IO, Huhtala HS, Kööbi T, Vaheri AI, Pasternack AI, Pörsti IH, Mustonen JT. (2006). Tenyear prognosis of Puumala Hantavirus-induced acute interstitial nephritis. Kidney Int, 69, 2043-2048.
85. Miettinen MH, Makela SM, Ala-Houhala IO, Huhtala HS, Koobi T, Vaheri AI, Pasternack AI, Porsti IH, Mustonen JT. (2009). Tubular proteinuria and glomerular filtration 6 years after puumala Hantavirus-induced acute interstitial nephritis. Nephron Clin Pract, 112, c115-c120.
86. Miettinen M, Mäkelä S, Haapala M, Helanterä A, Helin H, Vänttinen T, Mustonen J. (2011). Glomerulonephritis emerging shortly after Puumala Hantavirus infection: a report on 7 patients. Clin Nephrol, 75, 550-556.
87. Mori M, Rothman AL, Kurane I, Montoya JM, Nolte KB, Norman JE, Waite DC, Koster FT, Ennis FA. (1999). High levels of cytokineproducing cells in the lung tissues of patients with fatal Hantavirus pulmonary syndrome. J Infect Dis, 179, 295-302.
88. Mustonen J, Partanen J, Kanerva M, Pietilä K, Vapalahti O, Pasternack A, Vaheri A. (1996). Genetic susceptibility to severe course of nephropathia epidemica caused by Puumala Hantavirus. Kidney Int, 49, 217-221.
89. Navarrete M, Barrera C, Zaror L, Otth C. (2007). Rapid immunochromatographic test for Hantavirus andes contrasted with capture-IgM ELISA for detection of Andes-specific IgM antibodies. J Med Virol, 79, 41-44.
90. Nichol ST, Spiropoulou CF, Morzunov S, Rollin PE, Ksiazek TG, Feldmann H, Sanchez A, Childs J, Zaki S, Peters CJ. (1993). Genetic identification of a Hantavirus associated with an outbreak of acute respiratory illness. Science, 262, 914-917.
91. Outinen TK, Mäkelä SM, Ala-Houhala IO, Huhtala HS, Hurme M, Paakkala AS, Pörsti IH, Syrjänen JT, Mustonen JT. (2010). The severity of Puumala Hantavirus induced nephropathia epidemica can be better evaluated using plasma interleukin-6 than C-reactive protein determinations. BMC Infect Dis, 10, 132.
92. Paakkala A, Järvenpää R, Mäkelä S, Huhtala H, Mustonen J.(2011). Pulmonary high-resolution computed tomography findings in nephropathia epidemica. Eur J Radiol. Doi: 10.1016/j.ejrad.2011.04.049.
93. Paakkala A, Mäkelä S, Hurme M, Partanen J, Huhtala H, Mustonen J. (2008). Association of chest radiography findings with host-related genetic factors in patients with nephropathia epidemica. Scand J Infect Dis, 40, 254-258.
94. Pal E, Strle F, Avsic-Zupanc T. (2005). Hemorrhagic fever with renal syndrome in the Pomurje region of Slovenia-an 18-year survey. Wien Klin Wochenschr, 117, 398-405.
95. Papa A, Johnson AM, Stockton PC, Bowen MD, Spiropoulou CF, Alexiou-Daniel S, Ksiazek TG, Nichol ST, Antoniadis A. (1998). Retrospective serological and genetic study of the distribution of Hantaviruses in Greece. J Med Virol, 55, 321-327.
96. Papa A, Nemirov K, Henttonen H, Niemimaa J, Antoniadis A, Vaheri A, Plyusnin A, Vapalahti O. (2001). Isolation of Dobrava virus from Apodemus flavicollis in Greece. J Clin Microbiol, 39, 2291-2293.
97. PAHO (Pan American Health Organization). (2004). Number of Cases and Deaths from Hantavirus Pulmonary Syndrome (HPS). Available at: http://www.paho.org/english/ad/dpc/cd/hantavirus-1993-2004.htm. Accessed on 22 February 2012.
98. Pepini T, Gorbunova EE, Gavrilovskaya IN, Mackow JE, Mackow ER. (2010). Andes virus regulation of cellular microRNAs contributes to Hantavirus-induced endothelial cell permeability. J Virol, 84, 11929-11936.
99. Peters CJ, Khan AS. (2002). Hantavirus pulmonary syndrome: the new American hemorrhagic fever. Clin Infect Dis, 34, 1224-1231.
100. Prince HE, Su X, Hogrefe WR. (2007). Utilization of Hantavirus antibody results generated over a five-year period to develop an improved serologic algorithm for detecting acute Sin Nombre Hantavirus infection. J Clin Lab Anal, 21, 7-13.
101. Puljiz I, Kuzman I, Markotic A, Turcinov D, Matic M, Makek N. (2005). Electrocardiographic changes in patients with haemorrhagic fever with renal syndrome. Scand J Infect Dis, 37, 594-598.
102. Qian DY, Ding YS, Chen GF, Ding JJ, Chen YX, Lu TF, Wang ZX, Smego RA Jr. (1990). A placebo-controlled clinical trial of prednisone in the treatment of early hemorrhagic fever. J Infect Dis, 162, 1213-1214.
103. Raftery MJ, Kraus AA, Ulrich R, Krüger DH, Schönrich G. (2002). Hantavirus infection of dendritic cells. J Virol, 76, 10724-10733.
104. Rasmuson J, Andersson C, Norrman E, Haney M, Evander M, Ahlm C. (2011). Time to revise the paradigm of Hantavirus syndromes? Hantavirus pulmonary syndrome caused by European Hantavirus. Eur J Clin Microbiol Infect Dis, 30, 685-690.
105. Ray N, Whidby J, Stewart S, Hooper JW, Bertolotti-Ciarlet A. (2010). Study of Andes virus entry and neutralization using a pseudovirion system. J Virol Methods, 163, 416-423.
106. Raymond T, Gorbunova E, Gavrilovskaya IN, Mackow ER. (2005). Pathogenic Hantaviruses bind plexin-semaphorin-integrin domains present at the apex of inactive, bent αvβ3 integrin conformers. Proc Natl Acad Sci USA, 102, 1163-1168.
107. Rivers MN, Alexander JL, Rohde RE, Pierce JR Jr. (2009). Hantavirus pulmonary syndrome in Texas: 1993-2006. South Med J, 102, 36-41.
108. Rusnak JM, Byrne WR, Chung KN, Gibbs PH, Kim TT, Boudreau EF, Cosgriff T, Pittman P, Kim KY, Erlichman MS, Rezvani DF, Huggins JW. (2009). Experience with intravenous ribavirin in the treatment of hemorrhagic fever with renal syndrome in Korea. Antiviral Res, 81, 68-76.
109. Saggioro FP, Rossi MA, Duarte MI, Martin CC, Alves VA, Moreli ML, Figueiredo LT, Moreira JE, Borges AA, Neder L. (2007). Hantavirus infection induces a typical myocarditis that may be responsible for myocardial depression and shock in Hantavirus pulmonary syndrome. J Infect Dis, 195, 1541-1549.
110. Sakhautdinov VG, Galimov OV, Nurtdinov MA, Sibaev IM. (2001). Differential diagnosis of hemorrhagic fever with renal syndrome and acute surgical diseases of abdominal organs. Khirurgiia (Mosk), 3, 23-25.
111. Saksida A, Duh D, Korva M, Avsic-Zupanc T. (2008). Dobrava virus RNA load in patients who have hemorrhagic fever with renal syndrome. J Infect Dis, 197, 681-685.
112. Saksida A, Duh D, Wraber B, Dedushaj I, Ahmeti S, Avsic-Zupanc T. (2010). Interacting roles of immune mechanisms and viral load in the pathogenesis of Crimean-Congo hemorrhagic fever. Clin. Vaccine Immunol. 17,1086-1093.
113. Saksida A, Wraber B, Avšic-Županc T. (2011). Serum levels of inflammatory and regulatory cytokines in patients with hemorrhagic fever with renal syndrome. BMC Infect Dis, 11, 142.
114. Sane J, Laine O, Mäkelä S, Paakkala A, Jarva H, Mustonen J, Vapalahti O, Meri S, Vaheri A. (2011). Complement activation in Puumala Hantavirus infection correlates with disease severity. Ann Med. Doi:10.3109/07853890.2011.573500.
115. Sargianou M, Watson DC, Kampiotis D, Papa A, Economopoulou A, Gogos C, Panos G. Febrile disease in a Bulgarian emigrant with acute renal failure, thrombocytopenia, bilateral subconjunctival haemorrhage and hypoxemia. J Clin Virol. DOI: 10.1016/j. jcv.2012.01.019 (Epub ahead of print).
116. Schilling S, Emmerich P, Klempa B, Auste B, Schnaith E, Schmitz H, Krüger DH, Günther S, Meisel H. (2007). Hantavirus disease outbreak in Germany: limitations of routine serological diagnostics and clustering of virus sequences of human and rodent origin. J Clin Microbiol, 45, 3008-3014.
117. Schubert J, Tollmann F, Weissbrich B. (2001). Evaluation of a pan-reactive Hantavirus enzyme immunoassay and of a Hantavirus immunoblot for the diagnosis of nephropathia epidemica. J Clin Virol, 21, 63-74.
118. Schütt M, Meisel H, Krüger DH, Ulrich R, Dalhoff K, Dodt C. (2004). Life-threatening Dobrava Hantavirus infection with unusually extended pulmonary involvement. Clin Nephrol, 62, 54-57.
119. Seitsonen E, Hynninen M, Kolho E, Kallio-Kokko H, Pettilä V. (2006). Corticosteroids combined with continuous veno-venous hemodiafiltration for treatment of Hantavirus pulmonary syndrome caused by Puumala virus infection. Eur J Clin Microbiol Infect Dis, 25, 261-266.
120. Severson WE, Schmaljohn CS, Javadian A, Jonsson CB. (2003). Ribavirin causes error catastrophe during Hantaan virus replication. J Virol, 77, 481-488.
121. Shrivastava-Ranjan P, Rollin PE, Spiropoulou CF. (2010). Andes virus disrupts the endothelial cell barrier by induction of vascular endothelial growth factor and downregulation of VE-cadherin. J Virol, 84, 11227-11234.
122. Shutov AM, Savinova GA, Kiselev LI, Smirnov MN, Iudintseva EV. (2002). Use of recombinant interleukin-2 in hemorrhagic fever with renal syndrome. Klin Med (Mosk), 80, 54-57.
123. Sidel'nikov IuN, Martynenko AIu. 2001. Outcome of antibiotic therapy in patients with hemorrhagic fever with renal syndrome. Ter Arkh, 73, 78-81.
124. Song JW, Song KJ, Baek LJ, Frost B, Poncz M, Park K. (2005). In vivo characterization of the integrin β3 as a receptor for Hantaan virus cellular entry. Exp Mol Med, 37, 121-127.
125. Stojanovic M, Pekic S, Cvijovic G, Miljic D, Doknic M, Nikolic-Djurovic M, Micic D, Hrvacevic R, Nesic V, Popovic V. (2008). High risk of hypopituitarism in patients who recovered from hemorrhagic fever with renal syndrome. J Clin Endocrinol Metab, 93, 2722-2728.
126. Teissier E, Zandomeneghi G, Loquet A, Lavillette D, Lavergne JP, Montserret R, Cosset FL, Böckmann A, Meier BH, Penin F, Pécheur EI. (2011). Mechanism of inhibition of enveloped virus membrane fusion by the antiviral drug arbidol. PLoS ONE, 6, e15874.
127. Terajima M, Hendershot JD 3rd, Kariwa H, Koster FT, Hjelle B, Goade D, DeFronzo MC, Ennis FA. (1999). High levels of viremia in patients with the Hantavirus pulmonary syndrome. J Infect Dis, 180, 2030-2034.
128. Toivanen AL, Valanne L, Tatlisumak T. (2002). Acute disseminated encephalomyelitis following nephropathia epidemica. Acta Neurol Scand, 105, 333-336.
129. Tulumovic D, Hukic M, Mesic E, Sabovic S, Tulumovic A. (2003). Ultrasound findings on abdominal organs in the acute phase of hemorrhagic fever with renal syndrome. Acta Med Croatica, 57, 427-431.
130. Tulumovic D, Imamovic G, Mesic E, Hukic M, Tulumovic A, Imamovic A, Zerem E. (2010). Comparison of the effects of Puumala and Dobrava viruses on early and long-term renal outcomes in patients with haemorrhagic fever with renal syndrome. Nephrology (Carlton), 15, 340-343.
131. Vaheri A, Vapalahti O, Plyusnin A. (2008). How to diagnose Hantavirus infections and detect them in rodents and insectivores. Rev Med Virol, 18, 277-288.
132. Valdivieso F, Vial P, Ferres M, Ye C, Goade D, Cuiza A, Hjelle B. (2006). Neutralizing antibodies in survivors of Sin Nombre and Andes Hantavirus infection. Emerging Infect Dis, 12, 166-168.
133. Vapalahti K, Virtala AM, Vaheri A, Vapalahti O. (2010). Case-control study on Puumala virus infection: smoking is a risk factor. Epidemiol Infect, 138, 576-584.
134. Vapalahti O, Mustonen J, Lundkvist A, Henttonen H, Plyusnin A, Vaheri A. (2003). Hantavirus infections in Europe. Lancet Infect Dis, 3, 653-661.
135. Vetcha S, Wilkins E, Yates T, Hjelle B. (2002). Rapid and sensitive handheld biosensor for detection of Hantavirus antibodies in wild mouse blood samples under field conditions. Talanta, 58, 517-528.
136. Wang L, Li XL, Dai Y, Qiu ZF, Li TS. (2008). The dynamics of T lymphocyte subsets in hemorrhagic fever with renal syndrome. Zhonghua Nei Ke Za Zhi, 47, 654-657.
137. Watson DC, Sargianou M, Panos G. (2012). Interleukin-12 (IL-12)/IL-10 Ratio as a Marker of Disease Severity in Crimean-Congo Hemorrhagic Fever. Clin. Vaccine Immunol. doi:10.1128/CVI.00030-12. In press.
138. Xu R, Yang XY, Yang DF, Zou CY, Gong PL, Zeng FD. (2009). Phase I evaluation of the safety and pharmacokinetics of a singledose intravenous injection of a murine monoclonal antibody against Hantaan virus in healthy volunteers. Antimicrob Agents Chemother, 53, 5055-5059.
139. Xu ZY, Guo CS, Wu YL, Zhang XW, Liu K. (1985). Epidemiological studies of hemorrhagic fever with renal syndrome: analysis of risk factors and mode of transmission. J Infect Dis, 152, 137-144.
140. Yang J, Chen R, Wei J, Zhang F, Zhang Y, Jia L, Yan Y, Luo W, Cao Y, Yao L, Sun J, Xu Z, Yang A. (2010). Production and characterization of a recombinant single-chain antibody against Hantaan virus envelop glycoprotein. Appl Microbiol Biotechnol, 86, 1067-1075.
141. Yelleti S, Wilkins E. (2004). Design of an automated immunosensor device for fast detection of Hantavirus in mice blood. Sens Actuators B Chem, 97, 298-306.
142. Yu ZQ, Wang Y, Zeng QY, Chen LY, Wang JX, Yang JX, Li SH, Yang BS. (2007). Observations on clinic curative effect of oxymatrine to cure hemorrhagic fever with renal syndrome (HFRS). Zhonghua Yi Xue Za Zhi, 87, 2126-2128.
143. Zaki SR, Greer PW, Coffield LM, Goldsmith CS, Nolte KB, Foucar K, Feddersen RM, Zumwalt RE, Miller GL, Khan AS. (1995). Hantavirus pulmonary syndrome. Pathogenesis of an emerging infectious disease. Am J Pathol, 146, 552-579.
144. Zhang YZ, Zou Y, Fu ZF, Plyusnin A. (2010). Hantavirus infections in humans and animals, China. Emerging Infect Dis, 16, 1195-1203.
145. Zhang X, Chen HY, Zhu LY, Zeng LL, Wang F, Li QG, Shao FJ, Jiang HQ, Liu SJ, Ma YJ, Zhu Y, Ma YJ. (2011). Comparison of Hantaan and Seoul viral infections among patients with hemorrhagic fever with renal syndrome (HFRS) in Heilongjiang, China. Scand J Infect Dis, 43, 632-641.
146. Zou Z, Chen H, Schmaier AA, Hynes RO, Kahn ML. (2007). Structure-function analysis reveals discrete β3 integrin insideout and outside-in signaling pathways in platelets. Blood, 109, 3284-3290.